Development and validation of a molecular classifier of meningiomas.
Saved in:
| Title: | Development and validation of a molecular classifier of meningiomas. |
|---|---|
| Authors: | Landry AP; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Wang JZ; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Liu J; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Patil V; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Gui C; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Patel Z; Temerty School of Medicine, University of Toronto, Toronto, Ontario, Canada., Ajisebutu A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Ellenbogen Y; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Wei Q; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Singh O; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Sosa J; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Mansouri S; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Wilson C; Department of Neurosurgery, University of Oklahoma Health Sciences Center, Tulsa, Oklahoma, USA., Cohen-Gadol AA; Department of Neurological Surgery, Keck School of Medicine, USC, Los Angeles, California, USA., Zaazoue MA; Department of Orthopedic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.; Department of Neurological Surgery, Indiana University, Indianapolis, Indiana, USA., Tabatabai G; Department of Neurology and Interdisciplinary Neuro-Oncology, Center for Neuro-Oncology, Comprehensive Cancer Center, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies,' Eberhard Karls University Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany., Tatagiba M; Department of Neurosurgery, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard Karls University Tübingen, Tübingen, Germany., Behling F; Department of Neurosurgery, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard Karls University Tübingen, Tübingen, Germany., Barnholtz-Sloan JS; Center for Biomedical Informatics & Information Technology (CBIIT), National Cancer Institute, Bethesda, Maryland, USA.; Trans Divisional Research Program (TDRP), Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute, Bethesda, Maryland, USA.; Central Brain Tumor Registry of the United States, Hinsdale, Illinois, USA., Sloan AE; Piedmont Brain Tumor Center, Atlanta, Georgia, USA.; Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA., Chotai S; Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Chambless LB; Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Rebchuk AD; Division of Neurosurgery, University of British Columbia, Vancouver, British Columbia, Canada., Makarenko S; Division of Neurosurgery, University of British Columbia, Vancouver, British Columbia, Canada., Yip S; Department of Pathology & Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Mansouri A; Department of Neurosurgery, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA., Tsang DS; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Aldape K; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Gao A; Division of Laboratory Medicine and Pathobiology, University Health Network, Toronto, Ontario, Canada., Nassiri F; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Zadeh G; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada. |
| Corporate Authors: | International Consortium on Meningiomas (ICOM) |
| Source: | Neuro-oncology [Neuro Oncol] 2025 Jun 21; Vol. 27 (5), pp. 1258-1269. |
| Publication Type: | Journal Article; Validation Study |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1523-5866 |
|---|---|
| DOI: | 10.1093/neuonc/noae242 |
